Halo Collective Inc (HCANF)
0.0001
0.00 (0.00%)
USD |
OTCM |
Jun 25, 16:00
Halo Collective Revenue (Quarterly): 3.569M for June 30, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 3.569M |
| March 31, 2023 | 4.620M |
| December 31, 2022 | 4.566M |
| September 30, 2022 | 5.541M |
| June 30, 2022 | 6.87M |
| March 31, 2022 | 7.562M |
| December 31, 2021 | 8.366M |
| September 30, 2021 | 8.739M |
| June 30, 2021 | 9.136M |
| March 31, 2021 | 9.939M |
| December 31, 2020 | 5.120M |
| September 30, 2020 | 6.830M |
| June 30, 2020 | 5.243M |
| March 31, 2020 | 4.449M |
| December 31, 2019 | 2.727M |
| September 30, 2019 | 7.151M |
| June 30, 2019 | 9.552M |
| March 31, 2019 | 8.718M |
| December 31, 2018 | 3.040M |
| September 30, 2018 | 3.596M |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 |
| Date | Value |
|---|---|
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 | |
| March 31, 2012 | |
| December 31, 2011 | |
| September 30, 2011 | |
| June 30, 2011 | |
| March 31, 2011 |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
2.727M
Minimum
Dec 2019
9.939M
Maximum
Mar 2021
6.469M
Average
6.830M
Median
Sep 2020
Revenue (Quarterly) Benchmarks
| CEN Biotech Inc | 0.0941M |
| Acasti Pharma Inc | -- |
| Aurinia Pharmaceuticals Inc | 45.10M |
| Edesa Biotech Inc | -- |
| Lexaria Bioscience Corp | 0.145M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -6.851M |
| Total Expenses (Quarterly) | 5.578M |
| EPS Diluted (Quarterly) | -0.05 |
| Gross Profit Margin (Quarterly) | 51.34% |
| Profit Margin (Quarterly) | -192.0% |